Abstract
Although debated, patent foramen ovale (PFO) is still a popular field of interest for catheter-based interventions. While there is a common agreement about the management of patients with interatrial left-to-right shunts as secundum atrial septal defects, there is no complete agreement on which is the best management of PFO patients. In PFO patients, the real challenge for the clinician, besides secondary prevention of recurrent stroke, is to understand which are the higher-risk patients to refer for treatment and which is the proper device to use among the variety of double-umbrella or stent devices in the market. Different meta-analysis and registries suggested that interventional therapy is the most effective treatment at least with a specific device, but so far only few robust evidences have been only recently produced. The main anatomical-functional characteristics of interatrial septum, obtained with the current available diagnostic tools, such as transcranial Doppler, transthoracic, and transesophageal echocardiography together with a meticulous evaluation of patient’s history and clinical features, remain of paramount importance in patient selection and preoperative evaluation.
Keywords
- Left Ventricular Assist Device
- Migraine With Aura
- Interatrial Septum
- Transcatheter Closure
- Cryptogenic Stroke
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Marelli AJ, Mackie AS, Msc RI, Rahme E, Pilote L. Congenital heart disease in the general population. Changing prevalence and age distribution. Circulation. 2007;115:163–72.
Kilner PJ, Yang GZ, Wilkes AJ, Mohiaddin RH, Firmin DN, Yacoub MH. Asymmetric redirection of flow through the heart. Nature. 2000;404:759–61.
Rigatelli G. Patent foramen ovale: the evident paradox between the apparently simple treatment and the really complex pathophysiology. J Cardiovasc Med (Hagerstown). 2007;8:300–4.
Langholz D, Louie EK, Konstadt SN, Rao TL, Scanlon PJ. Transesophageal echocardiographic demonstration of distinct mechanisms for right to left shunting across a patent foramen ovale in the absence of pulmonary hypertension. J Am Coll Cardiol. 1991;18:1112–7.
Nootens MT, Berarducci LA, Kaufmann E, Devries S, Rich S. The prevalence and significance of a patent foramen ovale in pulmonary hypertension. Chest. 1993;104:1673–5.
Konstantinides S, Geibel A, Kasper W, Olschewski M, Blumel L, Just H. Patent foramen ovale is an important predictor of adverse outcome in patients with mayor pulmonary embolism. Circulation. 1998;97:1946–51.
Shanoudy H, Soliman A, Raggi P, Liu JW, Russell DC, Jarmukli NF. Prevalence of patent foramen ovale and its contribution to hypoxemia in patients with obstructive sleep apnea. Chest. 1998;113:91–6.
Soliman A, Shanoudy H, Liu J, Russell DC, Jarmukli NF. Increased prevalence of patent foramen ovale in patient with severe chronic obstructive pulmonary disease. J Am Soc Echocardiogr. 1999;12:99–105.
Rietvel AP, Merrman L, Essed CD, Trimbos JB, Hagemiejer F. Right-to-left shunt, with severe hypoxemia, at the atrial level in a patient with hemodynamically important right ventricular infarction. JACC. 1982;2:776–9.
Giebler R, Kollenberg B, Pohlen G, Peters J. Effect of positive end-expiratory pressure on the incidence of venous air embolism and on the cardiovascular response to the sitting position during neurosurgery. Br J Anaesth. 1998;80:30–5.
Gallaher ME, Sperling DR, Gwinn JL, Meyer BW, Fyler DC. Functional drainage of the inferior vena cava into the left atrium-three cases. Am J Cardiol. 1963;12:561–6.
Schoevvaerdts D, Gonzalez M, Evrard P, Buche M, Installe E. Patent foramen ovale: a cause of significant post-coronary and bypass grafting morbidity. Cardiovasc Surg. 2002;10:615–7.
Laybourn KA, Martin ET, Cooper RAS, Holman WL. Platypnea and orthodeoxia: shunting associated with an aortic aneurysm. J Thorac Cardiovasc Surg. 1977;113:955–6.
Smeenk FWJM, Postmus PE. Interatrial right-to-left shunting developing after pulmonary resection in the absence of elevated right-sided pressure. Chest. 1993;103:528–31.
Klepper JI, Seifer F, Lawson WF, et al. Intracardiac right-to-left shunting following cardiac surgery. Am Heart J. 1988;116:189–92.
Sievert H, Ruygrok P, Salkeld M, Baumgartner H, Meier B, Windecker S, Juliard JM, Aubry P, Tiefenbacher C, Krumsdorf U, Vermeersch P, Ewert P, Piéchaud JF. Transcatheter closure of patent foramen ovale with radiofrequency: acute and intermediate term results in 144 patients. Catheter Cardiovasc Interv. 2009;73(3):368–73. doi:10.1002/ccd.21809.
Aral M, Mullen M. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale. Catheter Cardiovasc Interv. 2015;85(6):1058–65.
Sievert H, Wunderlich N, Reiffenstein I, Ruygrok P, Grube E, Buellesfeld L, Meier B, Schofer J, Muller D, Jones RK, Gillam L. Initial clinical experience with the Coherex FlatStent™ and FlatStent™ EF PFO closure system for in-tunnel PFO closure: results of the Coherex-EU study. Catheter Cardiovasc Interv. 2014;83(7):1135–43. doi:10.1002/ccd.24565. Epub 2013 Nov 27.
Mügge A, Daniel WG, Angermann C, Spes C, Khandheria BK, Kronzon I, Freedberg RS, Keren A, Denning K, Engberding R, et al. Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation. 1995;91(11):2785–92.
Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with Paradoxical Embolism Study Group. Neurology. 1996;46(5):1301–5.
Cujec B, Mainra R, Johnson DH. Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks. Can J Cardiol. 1999;15(1):57–64.
Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J, Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001;345(24):1740–6.
Mattioli AV, Aquilina M, Oldani A, Longhini C, Mattioli G. Atrial septal aneurysm as a cardioembolic source in adult patients with stroke and normal carotid arteries. A multicentre study. Eur Heart J. 2001;22(3):261–8.
Lamy C, Giannesini C, Zuber M, Arquizan C, Meder JF, Trystram D, Coste J, Mas JL. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA study. Atrial Septal Aneurysm. Stroke. 2002;33(3):706–11.
Furlan AJ, CLOSURE I Investigators. PFO closure: CLOSURE. Stroke. 2013;44(6 Suppl 1):S45–7.
Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, Felberg R, Herrmann H, Kar S, Landzberg M, Raizner A, Wechsler L, CLOSURE I Investigators. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366(11):991–9.
Serena J, Marti-Fàbregas J, Santamarina E, Rodríguez JJ, Perez-Ayuso MJ, Masjuan J, Segura T, Gállego J, Dávalos A, CODICIA, Right-to-Left Shunt in Cryptogenic Stroke Study, Stroke Project of the Cerebrovascular Diseases Study Group, Spanish Society of Neurology. Recurrent stroke and massive right-to-left shunt: results from the prospective Spanish multicenter (CODICIA) study. Stroke. 2008;39(12):3131–6.
Horner S, Niederkorn K, Gattringer T, Furtner M, Topakian R, Lang W, Maier R, Gamillscheg A, Fazekas F. Management of right-to-left shunt in cryptogenic cerebrovascular disease: results from the observational Austrian paradoxical cerebral embolism trial (TACET) registry. J Neurol. 2013;260(1):260–7.
Khattab AA, Windecker S, Jüni P, Hildick-Smith D, Dudek D, Andersen HR, Ibrahim R, Schuler G, Walton AS, Wahl A, Mattle HP, Meier B. Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design. Trials. 2011;12:56.
Carroll JD, Saver JL, Thaler DE, for the RESPECT Investigators, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013;368:1092–100.
Ma B, Liu G, Chen X, Zhang J, Liu Y, Shi J. Risk of stroke in patients with patent foramen ovale: an updated meta-analysis of observational studies. J Stroke Cerebrovasc Dis. 2014;23(5):1207–15.
Capodanno D, Milazzo G, Vitale L, Di Stefano D, Di Salvo M, Grasso C, Tamburino C. Updating the evidence on patent foramen ovale closure versus medical therapy in patients with cryptogenic stroke: a systematic review and comprehensive meta-analysis of 2,303 patients from three randomised trials and 2,231 patients from 11 observational studies. EuroIntervention. 2014;9(11):1342–9.
Khan AR, Bin Abdulhak AA, Sheikh MA, Khan S, Erwin PJ, Tleyjeh I, Khuder S, Eltahawy EA. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis. JACC Cardiovasc Interv. 2013;6(12):1316–23.
Pickett CA, Villines TC, Ferguson MA, Hulten EA. Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials. Tex Heart Inst J. 2014;41(4):357–67.
Stortecky S, da Costa BR, Mattle HP, Carroll J, Hornung M, Sievert H, Trelle S, Windecker S, Meier B, Jüni P. Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis. Eur Heart J. 2015;36(2):120–8.
Patti G, Pelliccia F, Gaudio C, Greco C. Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale. Am J Cardiol. 2015;115(6):837–43.
Wilmshurst P, Nightingale S. The role of cardiac and pulmonary pathology in migraine: a hypothesis. Headache. 2006;46:429–34.
Kaaro J, Partonene T, Naik P, Hadjikhani N. Is migraine a lateralization defect? Neuroreport. 2008;19:1351–3.
Rigatelli G, Aggio S, Cardaioli P, et al. Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm: an alternative concurrent mechanism for arterial embolism? JACC Cardiovasc Interv. 2009;2:655–62.
Nozari A, Dilekoz E, Sukhotinsky I, et al. Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol. 2010;67:221–9.
Tarantini G, D'Amico G, Bettella N, Mojoli M, Rigatelli G. Patent foramen ovale closure and migraine time course: clues for positive interaction. Int J Cardiol. 2015;195:235–6.
Baker JE, Stratmann G, Hoopes C, Donateillo R, Tseng E, Russell IA. Profound hypoxemia resulting from shunting across an inadvertent atrial septal tear after left ventricular assist device placement. Anesth Analg. 2004;98:937–40.
Schulman LL, Smith CR, Drusin R, Rose EA, Enson Y, Reemtsma K. Patent foramen ovale complicating heart transplantation. A window on posttransplantation hemodynamics. Chest. 1987;92:569–72.
Rigatelli G, Faggian G, Cardaioli P, Mazzucco A. Contemporary management of patent foramen ovale in patients undergoing ventricular assisting devices or heart transplantation. J Cardiovasc Med (Hagerstown). 2009;10(1):9–12.
Thaler DE, Di Angelantonio E, Di Tullio MR, et al. The risk of paradoxical embolism (RoPE) study: initial description of the complete database. Int J Stroke. 2013;8:612–9.
Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al; American Society of Echocardiography’s Nomenclature and Standards Committee, Task Force on Chamber Quantification, American College of Cardiology Echocardiography Committee, American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79–108.
Anzola GP, Morandi E, Casilli F, Onorato E. Different degrees of right-to left shunting predict migraine and stroke: data from 420 patients. Neurology. 2006;66:765–7.
Anzola GP, Morandi E, Casilli F, Onorato E. Does transcatheter closure of patent foramen ovale really “shut the door?”A prospective study with transcranial doppler. Stroke. 2004;35:2140–4.
Rigatelli G, Dell'Avvocata F, Cardaioli P, Giordan M, Braggion G, Aggio S, Chinaglia M, Mandapaka S, Kuruvilla J, Chen JP, Nanjundappa A. Permanent right-to-left shunt is the key factor in managing patent foramen ovale. J Am Coll Cardiol. 2011;58(21):2257–61.
Pristipino C, Anzola GP, Ballerini L, Bartorelli A, Cecconi M, Chessa M, Donti A, Gaspardone A, Neri G, Onorato E, Palareti G, Rakar S, Rigatelli G, Santoro G, Toni D, Ussia GP, Violini R, Italian Society of Invasive Cardiology (SICI-GISE), Italian Stroke Association (ISA-AIS), Italian Association of Hospital Neurologists, Neuroradiologists, Neurosurgeons (SNO), Congenital Heart Disease Study Group of Italian Society Of Cardiology, Italian Association Of Hospital Cardiologists (ANMCO), Italian Society Of Pediatric Cardiology (SICP), Italian Society of Cardiovascular Echography (SIEC), Italian Society of Hemostasis and Thrombosis (SISET). Management of patients with patent foramen ovale and cryptogenic stroke: a collaborative, multidisciplinary, position paper: executive summary. Catheter Cardiovasc Interv. 2013;82(1):122–9.
Messe SR, Silverman IE, Kizer JR, Homma S, Zahn C, Gronseth G, et al.; Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2004;62:1042–50.
Marcu CB, Beek AM, van Rossum AC. Clinical applications of cardiovascular magnetic resonance imaging. CMAJ. 2006;175:911–7.
Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP, PFO in Cryptogenic Stroke Study (PICSS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation. 2002;105:2625–31.
Agmon Y, Khandheria BK, Meissner I, et al. Frequency of atrial septal aneurysm in patients with cerebral ischemic events. Circulation. 1999;99:1942–4.
Santamarina E, Gonzalez-Alujas MT, Munoz V, Rovira A, Rubiera M, Ribo M, et al. Stroke patients with cardiac atrial septal abnormalities: differential infarct patterns on DWI. J Neuroimaging. 2006;16:334–40.17.
Olivares-Reyes A, Chan S, Lazar EJ, Bandlamudi K, Narla V, Ong K. Atrial septal aneurysm: a new classification in two hundred five adults. J Am Soc Echocardiogr. 1997;10:644–56.
Schuchlenz HW, Saurer G, Weihs W, Rehak P. Persisting eustachian valve in adults: relation to patent foramen ovale and cerebrovascular events. J Am Soc Echocardiogr. 2004;17:231–3.
Schneider B, Hofmann T, Justen MH, Meinertz T. Chiari’s network: normal anatomic variant or risk factor for arterial embolic events? J Am Coll Cardiol. 1995;26:203–10.
Rigatelli G, Dell'Avvocata F, Braggion G, Giordan M, Chinaglia M, Cardatoli P. Persistent venous valves correlate with increased shunt and multiple preceding cryptogenic embolic events in patients with patent foramen ovale: an intracardiac echocardiographic study. Catheter Cardiovasc Interv. 2008;72:973–6.
Agmon Y, Meissner I, Tajik AJ, Seward JB, Petterson TM, Christianson TJ, O'Fallon WM, Wiebers DO, Khandheria BK. Clinical, laboratory, and transesophageal echocardiographic correlates of interatrial septal thickness: a population-based transesophageal echocardiographic study. J Am Soc Echocardiogr. 2005;18:175–82.
Christoph MH, Thomas K, Stefan PL, Torsten TB, Volkmar N. Lipomatous hypertrophy of the interatrial septum: a prospective study of incidence, imaging findings, and clinical symptoms. Chest. 2003;124:2068–73.
Goel SS, Tuzcu EM, Shishehbor MH, de Oliveira EI, Borek PP, Krasuski RA, Rodriguez LL, Kapadia SR. Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients. Am J Cardiol. 2009;103:124–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Rigatelli, G. (2017). Percutaneous Options, Patient Selection, and Preoperative Evaluation. In: Reimers, B., Moussa, I., Pacchioni, A. (eds) Percutaneous Interventions for Structural Heart Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-43757-6_20
Download citation
DOI: https://doi.org/10.1007/978-3-319-43757-6_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43755-2
Online ISBN: 978-3-319-43757-6
eBook Packages: MedicineMedicine (R0)